Elevance Health Q3 2026 Earnings: The $6.99 Beat Built on a 90.6% Benefit Ratio
Elevance Health Q3 2026: $6.99 adjusted EPS (+15.9%) as the benefit ratio fell 70bp to 90.6%, but a $412M investment-income jump covered all the pre-tax gain.
#elevance-health
Elevance Health
Financial analysis and earnings reports for Elevance Health, Inc. (ELV), the managed-care insurer behind Anthem Blue Cross Blue Shield and the Carelon pharmacy and health-services businesses